You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 161 No. 18, October 8, 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (6)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Fluconazole and Candida krusei Fungemia

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In their series on Candida krusei fungemia occurring at The University of Texas M. D. Anderson Cancer Center, Houston, from 1989 to 1996, Abbas et al1 observed an escalating frequency of this complication in patients with hematologic malignancies since 1993, when fluconazole became widely used as a prophylactic agent. These data confirm the association between fluconazole use and infections caused by this fungus that was previously reported at The University of Texas M. D. Anderson Cancer Center.2 However, this epidemiologic phenomenon continues to be debated, as other authors have not observed an impact of fluconazole use on the etiology of Candida infections, and the proportion of patients with cancer and candidemia due to C krusei seems not to have varied over the past 2 decades.3-9 Importantly, the emergence of C krusei infections in association with fluconazole prophylaxis has been noted only at single centers,1, 10-13 in contrast with the findings in . . . [Full Text of this Article]



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Candida krusei, a Multidrug-Resistant Opportunistic Fungal Pathogen: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005
Pfaller et al.
J. Clin. Microbiol. 2008;46:515-521.
ABSTRACT | FULL TEXT  

Epidemiology, Risk Factors, and Outcomes of Candida albicans Versus Non-albicans Candidemia in Nonneutropenic Patients
Davis et al.
The Annals of Pharmacotherapy 2007;41:568-573.
ABSTRACT | FULL TEXT  

Risk Factors for Pulmonary Aspergillus terreus Infection in Patients With Positive Culture for Filamentous Fungi
Caston et al.
Chest 2007;131:230-236.
ABSTRACT | FULL TEXT  

Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital
Munoz et al.
J Antimicrob Chemother 2005;55:188-193.
ABSTRACT | FULL TEXT  

Polymicrobial candidaemia revealed by peripheral blood smear and chromogenic medium
Yera et al.
J. Clin. Pathol. 2004;57:196-198.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.